Elevation of cytokines and antibodies in guinea pigs experimentally infected with Tunga penetrans

Abstract

Aim:Tungiasis caused by Tunga penetrans is a neglected tropical disease that majorly affects children, the elderly and persons living with disabilities in rural homes in sub-Saharan Africa. The disease is characterized by swelling and inflammation symptoms, especially on the hands and feet. However, it is unclear whether inflammatory responses induced by T. penetrans may be associated with alterations of cytokine and antibody profiles. The study evaluated the immunological changes: cytokine and antibody profiles of experimentally raised guinea pigs exposed to T. penetrans.

Methods:A total of 24 guinea pigs were experimented on; 16 were exposed to T. penetrans while 8 were controls. Blood samples were collected before and after exposure. Enzyme-linked immunosorbent assay (ELISA) technique was used to quantify cytokines and antibodies. Data analysis was performed using GraphPad Prism 10.4.

Results:At day 10 of post-infection, guinea pigs showed significant elevation (p < 0.05) of pro-inflammatory cytokines, tumor necrosis factor alpha (TNF-α) (235 pg/mL), and interferon gamma (IFN-γ) (425 pg/mL) in the serum. Anti-inflammatory cytokine had a delayed elevation, with interleukin-4 (IL-4) peaking to 357 pg/mL by day 15, while IL-10 rose to 367 pg/mL by day 15 of post-infection. Total systemic circulating levels of antibodies in serum were significantly elevated ( p < 0.05), with immunoglobulin E (IgE) elevating to 232 ng/mL while IgG peaking at 272 ng/mL on day 15 post-infection.

Conclusions:Pro-inflammatory cytokines elevated during the early stages of infection may serve as early markers for the infection, and their potential role in the pathogenesis of tungiasis needs to be explored further. The study has established that IgE and IgG are important antibodies that are produced in response to tungiasis, and their efficacy in controlling the infection needs to be further explored for potential alleviation of severe forms of the infection.

Keywords

Tungiasis / neglected tropical disease / cytokine / antibodies / Tunga penetrans / guinea pigs

References

[1] Abrha S, Heukelbach J, Peterson GM, Christenson JK, Carroll S, Kosari S, et al. Clinical interventions for tungiasis (sand flea disease): a systematic review. Lancet Infect Dis. 2021; 21: e234-45.

[2] Mutebi F, Krücken J, Feldmeier H, von Samsom-Himmelstjerna G. Clinical implications and treatment options of tungiasis in domestic animals. Parasitol Res. 2021; 120: 4113-23.

[3] Linardi PM. Fleas and Diseases. In: Arthropod Borne Diseases. Cham: Springer; 2017. pp. 517-36.

[4] Silvestri V, Mushi V, Ngasala B. Tungiasis. In: Vascular Damage in Neglected Tropical Diseases. Cham: Springer; 2024. pp. 81-9.

[5] Deka MA. Mapping the Geographic Distribution of Tungiasis in Sub-Saharan Africa. Trop Med Infect Dis. 2020; 5: 122.

[6] Deka MA, Morshed N. Geospatial Analysis of Tungiasis Disease Transmission Risk in East Africa. In: Braimah JA, Bisung E, Kuuire V, editors. Health Geography in Sub-Saharan Africa. Cham: Springer; 2023. pp. 177-93.

[7] Heukelbach J, Harvey TV, Calheiros CML. Tunga Spp. and Tungiasis in Latin America . In: Infectious Tropical Diseases and One Health in Latin America. Cham: Springer; 2022. pp. 151-68.

[8] Obebe OO, Aluko OO. Epidemiology of tungiasis in sub-saharan Africa: a systematic review and meta-analysis. Pathog Glob Health. 2020; 114: 360-9.

[9] Nagy N, Abari E, D’Haese J, Calheiros C, Heukelbach J, Mencke N, et al. Investigations on the life cycle and morphology of Tunga penetrans in Brazil . Parasitol Res. 2007; 101: 233-42.

[10] Nwalozie R, Ezenwaka CO. Tungiasis: Biology, Life Cycle, Epidemiology, Diagnosis, Prevention, and Treatment. South Asian J Parasitol. 2023; 6: 83-93.

[11] Mphande FA. Skin Disorders in Vulnerable Populations: Causes, Impacts and Challenges. Singapore: Springer; 2020.

[12] Leiferman KM, Peters MS. Eosinophil-Related Disease and the Skin. J Allergy Clin Immunol Pract. 2018; 6: 1462-82.e6.

[13] Feldmeier H, Heukelbach J, Eisele M, Sousa AQ, Barbosa LM, Carvalho CB. Bacterial superinfection in human tungiasis. Trop Med Int Health. 2002; 7: 559-64.

[14] Feldmeier H, Heukelbach J, Eisele M, Ribeiro R, Harms G, Mehlhorn H, et al. Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: III. Cytokine levels in peripheral blood of infected humans . Parasitol Res. 2003; 91: 298-303.

[15] Feldmeier H, Witt LH, Schwalfenberg S, Albuquerque Ribeiro R, Queiroz Cunha F, Harms G, et al. Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil. V. Cytokine concentrations in experimentally infected Wistar rats . Parasitol Res. 2004; 94: 371-6.

[16] Galli SJ, Metz M, Starkl P, Marichal T, Tsai M. Mast cells and IgE in defense against lethality of venoms: Possible “benefit” of allergy. Allergo J Int. 2020; 29: 46-62.

[17] Heukelbach J, Walton SF, Feldmeier H. Ectoparasitic infestations. Curr Infect Dis Rep. 2005; 7: 373-80.

[18] Vega-López F, Ritchie S. Skin Tropical Infections and Dermatology in Travellers. In: Principles and Practice of Travel Medicine. John Wiley & Sons, Inc.; 2013. pp. 165-96.

[19] Wells B, Burgess ST, McNeilly TN, Huntley JF, Nisbet AJ. Recent developments in the diagnosis of ectoparasite infections and disease through a better understanding of parasite biology and host responses. Mol Cell Probes. 2012; 26: 47-53.

[20] Birck MM, Tveden-Nyborg P, Lindblad MM, Lykkesfeldt J. Non-Terminal Blood Sampling Techniques in Guinea Pigs. J Vis Exp. 2014: e51982.

[21] Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, Smith D, et al. ; European Federation of Pharmaceutical Industries Association and European Centre for the Validation of Alternative Methods. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol. 2001; 21: 15-23.

[22] Parasuraman S, Raveendran R, Kesavan R. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010; 1: 87-93.

[23] Osorio-Pinzon J, Palencia A, Cruz-Calderon S, Rodriguez-Morales AJ. Myiasis and Tungiasis. Curr Trop Med Rep. 2021; 8: 112-20.

[24] Padilla-Carlin DJ, McMurray DN, Hickey AJ. The guinea pig as a model of infectious diseases. Comp Med. 2008; 58: 324-40.

[25] Feldmeier H, Eisele M, Van Marck E, Mehlhorn H, Ribeiro R, Heukelbach J. Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: IV. Clinical and histopathology . Parasitol Res. 2004; 94: 275-82.

[26] Liu X, Walton SF, Murray HC, King M, Kelly A, Holt DC, et al. Crusted scabies is associated with increased IL-17 secretion by skin T cells. Parasite Immunol. 2014; 36: 594-604.

[27] Mishra PK, Palma M, Bleich D, Loke P, Gause WC. Systemic impact of intestinal helminth infections. Mucosal Immunol. 2014; 7: 753-62.

[28] Bhat SA, Mounsey KE, Liu X, Walton SF. Host immune responses to the itch mite, Sarcoptes scabiei, in humans . Parasit Vectors. 2017; 10: 385.

[29] Walton SF, Pizzutto S, Slender A, Viberg L, Holt D, Hales BJ, et al. Increased Allergic Immune Response to Sarcoptes scabiei Antigens in Crusted versus Ordinary Scabies . Clin Vaccine Immunol. 2010; 17: 1428-38.

[30] Athanasiou LV, Spanou VM, Katsogiannou EG, Katsoulos PD. Hematological Features in Sheep with IgG and IgM Antibodies against Borrelia burgdorferi sensu lato . Pathogens. 2021; 10: 164.

[31] Sharaf MS. Scabies: Immunopathogenesis and pathological changes. Parasitol Res. 2024; 123: 149.

[32] Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol. 2004; 4: 211-22.

[33] Eberle JU, Voehringer D. Role of basophils in protective immunity to parasitic infections. Semin Immunopathol. 2016; 38: 605-13.